Breaking News Instant updates and real-time market news.

ZIOP

Ziopharm

$2.90 /

-0.025 (-0.85%)

14:20
11/29/20
11/29
14:20
11/29/20
14:20

Ziopharm comments on Institutional Shareholder Services' report

Ziopharm Oncology has issued a response to a report issued by Institutional Shareholder Services in connection with the consent solicitation initiated by WaterMill Asset Management, Robert Postma and certain other individuals. In its report, ISS recommends that Ziopharm shareholders reject WaterMill's attempt to remove half of the Ziopharm Board of Directors and to vote against the addition of Postma to the Board. Ziopharm "strongly recommends shareholders sign and return the Company's GREEN Consent Revocation Card." In a statement, the company said: "We are gratified that ISS acknowledges that removing half of Ziopharm's Board and replacing them with WaterMill's full slate of proposed candidates - including Mr. Postma, himself - would not be in the best interest of shareholders or the Company. In addition, we are pleased that ISS acknowledges the track record of Ziopharm's performance in recent years, which we believe underscores the long-term value potential in Ziopharm under the leadership of the current Board and management team. Importantly, while we have a great deal of respect for ISS, the report contains a number of factual mistakes. Additionally, key information in the public domain relating to WaterMill nominee Holger Weis raises questions regarding his suitability as a director." The company also said that Ziopharm's management team and Board believe "it is critical for shareholders to be aware of the following factual errors in the ISS report: ISS recommends in favor of fixing the Board size at seven, but their other recommendations would result in an eight-member board. ISS states that the Board "rejected" the resignations of Elan Ezickson and Dr. Scott Braunstein, but that is not correct. In fact, the Board never rejected these resignations. The Board promptly engaged two leading search firms to identify candidates in connection with the results of the 2020 annual meeting and has accepted resignations as soon as it has found suitable replacements. ISS reports Elan Ezickson attended 'fewer than 75 percent of meetings in 2019,' which is not accurate. Mr. Ezickson attended nearly 90% of Board and committee meetings in 2019. Mr. Ezickson attended fewer than 75% of meetings the year before that only because he was unable to participate in two special Board meetings that were called on short notice. ISS' review of Ziopharm's material weakness is incorrect. The ISS report notes 'there is nothing that prohibits the company from disclosing that remediation is underway,' when in fact Ziopharm has disclosed the remediation steps in several filings with the U.S. Securities and Exchange Commission, including in its most recent Form 10-Q filed on November 5, 2020. ISS also critiques the Board for the "retention of an overboarded director," but fails to note that the issue was remedied by the director's resignation from another board well in advance of the launch of the consent solicitation. Additionally, ISS recommends in favor of the election of WaterMill nominee Holger Weis arguing, among other things, that he 'served on a public company board.' However, the Company has not found any evidence that Mr. Weis has public company board experience, an assessment supported in WaterMill's own disclosures."

  • 05

    Feb

ZIOP Ziopharm
$2.90 /

-0.025 (-0.85%)

07/10/20 Lake Street
Ziopharm took 'important step' with start of CAR-T study, says Lake Street
06/19/20 Jefferies
Ziopharm initiated with a Buy at Jefferies
05/11/20 H.C. Wainwright
Ziopharm price target lowered to $5.50 from $6.50 at H.C. Wainwright
03/04/20
Fly Intel: Top five analyst initiations

TODAY'S FREE FLY STORIES

Periodicals
McKesson to replace some Moderna vaccine shots shipped too cold, Bloomberg says » 11:55
01/20/21
01/20
11:55
01/20/21
11:55
MCK

McKesson

$182.77 /

+0.29 (+0.16%)

, MRNA

Moderna

$122.82 /

-2.2 (-1.76%)

McKesson (MCK) said in a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MCK McKesson
$182.77 /

+0.29 (+0.16%)

MRNA Moderna
$122.82 /

-2.2 (-1.76%)

MCK McKesson
$182.77 /

+0.29 (+0.16%)

12/24/20 Morgan Stanley
Morgan Stanley sees greater FY22 COVID vaccine opportunity at McKesson
11/18/20 Jefferies
Drug distributors' pullback on Amazon news an overreaction, says Jefferies
11/18/20 Goldman Sachs
McKesson upgraded to Conviction Buy from Buy at Goldman Sachs
11/17/20 Goldman Sachs
Goldman says Amazon news likely to pressure entire pharmacy supply chain
MRNA Moderna
$122.82 /

-2.2 (-1.76%)

01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/06/21 Piper Sandler
Moderna price target raised to $170 after EU vaccine approval at Piper Sandler
01/04/21 Piper Sandler
Moderna shares warrant 'fresh look' after 41% pullback, says Piper Sandler
12/31/20 Ladenburg
UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg
MCK McKesson
$182.77 /

+0.29 (+0.16%)

MRNA Moderna
$122.82 /

-2.2 (-1.76%)

  • 19
    May
  • 12
    Feb
MCK McKesson
$182.77 /

+0.29 (+0.16%)

MRNA Moderna
$122.82 /

-2.2 (-1.76%)

MCK McKesson
$182.77 /

+0.29 (+0.16%)

MRNA Moderna
$122.82 /

-2.2 (-1.76%)

MCK McKesson
$182.77 /

+0.29 (+0.16%)

MRNA Moderna
$122.82 /

-2.2 (-1.76%)

Downgrade
PKO Bank Polski downgraded to Neutral from Overweight at JPMorgan » 11:52
01/20/21
01/20
11:52
01/20/21
11:52
PSZKY

PKO Bank Polski

$0.00 /

+ (+0.00%)

JPMorgan analyst Samuel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PSZKY PKO Bank Polski
$0.00 /

+ (+0.00%)

06/01/20 HSBC
PKO Bank Polski downgraded to Hold from Buy at HSBC
06/01/20 Societe Generale
PKO Bank Polski price target lowered to PLN 28 from PLN 30 at Societe Generale
06/01/20 JPMorgan
PKO Bank Polski downgraded to Neutral from Overweight at JPMorgan
Hot Stocks
Schneider National takes investment stake in TuSimple » 11:52
01/20/21
01/20
11:52
01/20/21
11:52
SNDR

Schneider National

$23.31 /

-0.03 (-0.13%)

Schneider announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
SNDR Schneider National
$23.31 /

-0.03 (-0.13%)

SNDR Schneider National
$23.31 /

-0.03 (-0.13%)

01/19/21 Credit Suisse
Schneider National upgraded to Outperform from Neutral at Credit Suisse
12/14/20 Wells Fargo
Schneider National downgraded to Underweight from Equal Weight at Wells Fargo
12/04/20
Evercore starts trucking coverage with preference for Old Dominion, Saia
12/04/20 Evercore ISI
Schneider National initiated with an In Line at Evercore ISI
SNDR Schneider National
$23.31 /

-0.03 (-0.13%)

Periodicals
EU seeks info from advertisers about Google's ad tech practices, Reuters says » 11:52
01/20/21
01/20
11:52
01/20/21
11:52
GOOG

Alphabet

$1,876.85 /

+86.37 (+4.82%)

, GOOGL

Alphabet Class A

$1,872.00 /

+88.85 (+4.98%)

European Union antitrust…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GOOG Alphabet
$1,876.85 /

+86.37 (+4.82%)

GOOGL Alphabet Class A
$1,872.00 /

+88.85 (+4.98%)

GOOG Alphabet
$1,876.85 /

+86.37 (+4.82%)

01/19/21 JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/15/21 MoffettNathanson
Alphabet price target raised to $2,100 from $1,900 at MoffettNathanson
01/12/21 Cowen
Alphabet price target raised to $2200 from $1900 at Cowen
01/11/21 Jefferies
Yelp downgraded to Hold on 'full' valuation at Jefferies
GOOGL Alphabet Class A
$1,872.00 /

+88.85 (+4.98%)

01/19/21 JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/19/21 KeyBanc
Alphabet price target to $2,060 from $1,970 at KeyBanc
01/15/21 MoffettNathanson
Alphabet price target raised to $2,100 from $1,900 at MoffettNathanson
01/11/21 Jefferies
Yelp downgraded to Hold on 'full' valuation at Jefferies
GOOG Alphabet
$1,876.85 /

+86.37 (+4.82%)

GOOGL Alphabet Class A
$1,872.00 /

+88.85 (+4.98%)

GOOG Alphabet
$1,876.85 /

+86.37 (+4.82%)

GOOGL Alphabet Class A
$1,872.00 /

+88.85 (+4.98%)

GOOG Alphabet
$1,876.85 /

+86.37 (+4.82%)

GOOGL Alphabet Class A
$1,872.00 /

+88.85 (+4.98%)

GOOG Alphabet
$1,876.85 /

+86.37 (+4.82%)

GOOGL Alphabet Class A
$1,872.00 /

+88.85 (+4.98%)

Periodicals
State Street to eliminate 1,200 positions this year, BI reports » 11:47
01/20/21
01/20
11:47
01/20/21
11:47
STT

State Street

$77.70 /

-0.82 (-1.04%)

State Street Corp. is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STT State Street
$77.70 /

-0.82 (-1.04%)

STT State Street
$77.70 /

-0.82 (-1.04%)

06:43 Today RBC Capital
State Street price target raised to $86 from $78 at RBC Capital
01/11/21 Piper Sandler
State Street price target raised to $81 from $69 at Piper Sandler
01/05/21 Wolfe Research
State Street downgraded to Underperform from Peer Perform at Wolfe Research
01/05/21 Goldman Sachs
State Street downgraded to Neutral from Buy at Goldman Sachs
STT State Street
$77.70 /

-0.82 (-1.04%)

STT State Street
$77.70 /

-0.82 (-1.04%)

STT State Street
$77.70 /

-0.82 (-1.04%)

Options
Spirit Airlines call volume above normal and directionally bullish » 11:45
01/20/21
01/20
11:45
01/20/21
11:45
SAVE

Spirit Airlines

$27.29 /

+0.605 (+2.27%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAVE Spirit Airlines
$27.29 /

+0.605 (+2.27%)

SAVE Spirit Airlines
$27.29 /

+0.605 (+2.27%)

01/14/21 Susquehanna
Spirit Airlines price target raised to $22 from $19 at Susquehanna
01/08/21 BofA
Spirit Airlines upgraded to Neutral from Underperform at BofA
12/23/20 Citi
Airline demand in early 2021 'looks soft,' says Citi
12/16/20
Fly Intel: Top five analyst downgrades
SAVE Spirit Airlines
$27.29 /

+0.605 (+2.27%)

  • 08
    May
SAVE Spirit Airlines
$27.29 /

+0.605 (+2.27%)

SAVE Spirit Airlines
$27.29 /

+0.605 (+2.27%)

SAVE Spirit Airlines
$27.29 /

+0.605 (+2.27%)

Recommendations
LafargeHolcim price target raised to CHF 57 from CHF 48 at UBS » 11:39
01/20/21
01/20
11:39
01/20/21
11:39
HCMLY

LafargeHolcim

$0.00 /

+ (+0.00%)

UBS analyst Gregor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HCMLY LafargeHolcim
$0.00 /

+ (+0.00%)

01/14/21 Berenberg
LafargeHolcim initiated with a Hold at Berenberg
01/08/21 JPMorgan
LafargeHolcim price target raised to CHF 59 from CHF 51 at JPMorgan
12/07/20 Jefferies
LafargeHolcim initiated with a Hold at Jefferies
11/18/20 Deutsche Bank
LafargeHolcim initiated with a Buy at Deutsche Bank
HCMLY LafargeHolcim
$0.00 /

+ (+0.00%)

Recommendations
HeidelbergCement price target raised to EUR 71.50 from EUR 68.50 at UBS » 11:38
01/20/21
01/20
11:38
01/20/21
11:38
HDELY

HeidelbergCement

$0.00 /

+ (+0.00%)

UBS analyst Gregor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HDELY HeidelbergCement
$0.00 /

+ (+0.00%)

01/14/21 Berenberg
HeidelbergCement initiated with a Buy at Berenberg
01/08/21 JPMorgan
HeidelbergCement price target raised to EUR 70 from EUR 60 at JPMorgan
01/06/21 Societe Generale
HeidelbergCement upgraded to Buy from Hold at Societe Generale
12/16/20 Credit Suisse
HeidelbergCement price target raised to EUR 69 from EUR 60 at Credit Suisse
Recommendations
GlaxoSmithKline price target raised to 1,450 GBp from 1,440 GBp at UBS » 11:38
01/20/21
01/20
11:38
01/20/21
11:38
GSK

GlaxoSmithKline

$37.81 /

-0.72 (-1.87%)

UBS analyst Laura…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GSK GlaxoSmithKline
$37.81 /

-0.72 (-1.87%)

GSK GlaxoSmithKline
$37.81 /

-0.72 (-1.87%)

09:56 Today
Fly Intel: Top five analyst downgrades
06:32 Today Credit Suisse
GlaxoSmithKline downgraded to Underperform from Neutral at Credit Suisse
05:29 Today Credit Suisse
GlaxoSmithKline downgraded to Underperform from Neutral at Credit Suisse
01/15/21 Deutsche Bank
GlaxoSmithKline initiated with a Hold at Deutsche Bank
GSK GlaxoSmithKline
$37.81 /

-0.72 (-1.87%)

GSK GlaxoSmithKline
$37.81 /

-0.72 (-1.87%)

GSK GlaxoSmithKline
$37.81 /

-0.72 (-1.87%)

GSK GlaxoSmithKline
$37.81 /

-0.72 (-1.87%)

Hot Stocks
First Eagle Alternative Credit COO, CFO Terry Olson to retire » 11:38
01/20/21
01/20
11:38
01/20/21
11:38
FCRD

First Eagle Alternative Capital

$3.70 /

+0.03 (+0.82%)

First Eagle Alternative…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FCRD First Eagle Alternative Capital
$3.70 /

+0.03 (+0.82%)

Recommendations
Ferguson price target raised to 10,050 GBp from 9,450 GBp at UBS » 11:37
01/20/21
01/20
11:37
01/20/21
11:37
FERGY

Ferguson

$0.00 /

+ (+0.00%)

UBS analyst Gregor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FERGY Ferguson
$0.00 /

+ (+0.00%)

01/14/21 Berenberg
Ferguson downgraded to Sell from Hold at Berenberg
01/05/21 UBS
Ferguson U.K. sale not that material, says UBS
01/05/21 RBC Capital
Ferguson forecasts adjusted at RBC Capital
12/09/20 Barclays
Ferguson price target raised to 9,000 GBp from 8,000 GBp at Barclays
Recommendations
CRH price target raised to 3,600 GBp from 3,450 GBp at UBS » 11:37
01/20/21
01/20
11:37
01/20/21
11:37
CRH

CRH

$44.88 /

-0.12 (-0.27%)

UBS analyst Gregor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRH CRH
$44.88 /

-0.12 (-0.27%)

CRH CRH
$44.88 /

-0.12 (-0.27%)

01/14/21 Berenberg
CRH initiated with a Hold at Berenberg
01/08/21 JPMorgan
CRH price target raised to EUR 41 from EUR 40 at JPMorgan
01/06/21 Societe Generale
CRH upgraded to Buy on apparent Democratic majority at Societe Generale
01/06/21 Societe Generale
CRH upgraded to Buy from Hold at Societe Generale
CRH CRH
$44.88 /

-0.12 (-0.27%)

Recommendations
Bankinter price target raised to EUR 4.60 from EUR 3.45 at UBS » 11:36
01/20/21
01/20
11:36
01/20/21
11:36
BKIMF

Bankinter

$0.00 /

+ (+0.00%)

UBS analyst Ignacio…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BKIMF Bankinter
$0.00 /

+ (+0.00%)

12/14/20 JPMorgan
Bankinter price target raised to EUR 3.60 from EUR 3.30 at JPMorgan
11/24/20 Morgan Stanley
Bankinter price target raised to EUR 4.15 from EUR 3.90 at Morgan Stanley
10/23/20 Barclays
Bankinter price target lowered to EUR 3.60 from EUR 3.80 at Barclays
10/23/20 UBS
Bankinter price target lowered to EUR 3.45 from EUR 3.55 at UBS
Recommendations
Bankia price target raised to EUR 1.52 from EUR 1.09 at UBS » 11:36
01/20/21
01/20
11:36
01/20/21
11:36
BNKXF

Bankia

$0.00 /

+ (+0.00%)

UBS analyst Ignacio…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BNKXF Bankia
$0.00 /

+ (+0.00%)

BNKXF Bankia
$0.00 /

+ (+0.00%)

12/14/20 JPMorgan
Bankia price target raised to EUR 1.20 from EUR 1.10 at JPMorgan
11/25/20 HSBC
Bankia downgraded to Hold from Buy at HSBC
10/29/20 UBS
Bankia price target lowered to EUR 1.09 from EUR 1.15 at UBS
10/20/20 UBS
Bankia price target lowered to EUR 1.15 from EUR 1.30 at UBS
BNKXF Bankia
$0.00 /

+ (+0.00%)

Periodicals
Tesla lowers Model 3 prices in Europe, Electrek reports » 11:35
01/20/21
01/20
11:35
01/20/21
11:35
TSLA

Tesla

$844.31 /

-0.26 (-0.03%)

Tesla has reduced Model 3…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$844.31 /

-0.26 (-0.03%)

TSLA Tesla
$844.31 /

-0.26 (-0.03%)

09:16 Today JPMorgan
JPMorgan boosts GM target to $63, calls 'significant contender' in autonomous
07:39 Today Deutsche Bank
Tesla price target raised to $890 from $705 at Deutsche Bank
06:48 Today Oppenheimer
Tesla price target raised to $1,036 from $486 at Oppenheimer
01/19/21 Jefferies
Tesla price target raised to $775 from $650 at Jefferies
TSLA Tesla
$844.31 /

-0.26 (-0.03%)

  • 14
    Feb
TSLA Tesla
$844.31 /

-0.26 (-0.03%)

TSLA Tesla
$844.31 /

-0.26 (-0.03%)

TSLA Tesla
$844.31 /

-0.26 (-0.03%)

Recommendations
Banco de Sabadell price target raised to EUR 0.40 from EUR 0.27 at UBS » 11:35
01/20/21
01/20
11:35
01/20/21
11:35
BNDSF

Banco de Sabadell

$0.00 /

+ (+0.00%)

UBS analyst Ignacio…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BNDSF Banco de Sabadell
$0.00 /

+ (+0.00%)

11/27/20 Keefe Bruyette
Sabadell downgraded to Underperform from Market Perform at Keefe Bruyette
11/05/20 UBS
Banco de Sabadell price target lowered to EUR 0.27 from EUR 0.28 at UBS
11/03/20 Deutsche Bank
Banco de Sabadell price target raised to EUR 0.45 at Deutsche Bank
10/20/20 UBS
Banco de Sabadell price target lowered to EUR 0.28 from EUR 0.30 at UBS
BNDSF Banco de Sabadell
$0.00 /

+ (+0.00%)

Recommendations
Bayer price target raised to EUR 55 from EUR 47 at Credit Suisse » 11:33
01/20/21
01/20
11:33
01/20/21
11:33
BAYRY

Bayer

$0.00 /

+ (+0.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BAYRY Bayer
$0.00 /

+ (+0.00%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

01/08/21 Morgan Stanley
Bayer price target lowered to EUR 66 from EUR 67 at Morgan Stanley
01/07/21 Morgan Stanley
CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley
12/07/20 Stifel
Atara Biotherapeutics price target raised to $33 from $28 at Stifel
12/07/20 Roth Capital
Bayer collaboration a testament to Atara's T-cell prowess, says Roth Capital
BAYRY Bayer
$0.00 /

+ (+0.00%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

Recommendations
Grifols price target lowered to EUR 26 from EUR 27 at Credit Suisse » 11:32
01/20/21
01/20
11:32
01/20/21
11:32
GRFS

Grifols

$19.38 /

-0.4 (-2.02%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GRFS Grifols
$19.38 /

-0.4 (-2.02%)

GRFS Grifols
$19.38 /

-0.4 (-2.02%)

01/13/21 Morgan Stanley
Grifols price target lowered to EUR 31 from EUR 32 at Morgan Stanley
12/09/20 Morgan Stanley
Grifols price target raised to EUR 32 from EUR 31 at Morgan Stanley
11/06/20 Morgan Stanley
Grifols price target raised to EUR 31 from EUR 30 at Morgan Stanley
10/30/20 Berenberg
Grifols price target lowered to EUR 24.50 from EUR 25.30 at Berenberg
GRFS Grifols
$19.38 /

-0.4 (-2.02%)

GRFS Grifols
$19.38 /

-0.4 (-2.02%)

Recommendations
Orion Oyj price target raised to EUR 35 from EUR 30 at Credit Suisse » 11:32
01/20/21
01/20
11:32
01/20/21
11:32
ORINF

Orion Oyj

$0.00 /

+ (+0.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Ahold Delhaize price target lowered to EUR 24 from EUR 25 at Credit Suisse » 11:30
01/20/21
01/20
11:30
01/20/21
11:30
ADRNY

Ahold Delhaize

$0.00 /

+ (+0.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADRNY Ahold Delhaize
$0.00 /

+ (+0.00%)

ADRNY Ahold Delhaize
$0.00 /

+ (+0.00%)

11/20/20 Stifel
Ahold Delhaize upgraded to Hold from Sell at Stifel
11/10/20 Morgan Stanley
Ahold Delhaize price target raised to EUR 25.40 from EUR 25 at Morgan Stanley
11/09/20 Credit Suisse
Ahold Delhaize initiated with a Neutral at Credit Suisse
11/05/20 JPMorgan
Ahold Delhaize price target lowered to EUR 22 from EUR 23 at JPMorgan
Recommendations
easyJet price target raised to 934 GBp from 840 GBp at Credit Suisse » 11:29
01/20/21
01/20
11:29
01/20/21
11:29
ESYJY

easyJet

$0.00 /

+ (+0.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ESYJY easyJet
$0.00 /

+ (+0.00%)

12/31/20
Fly Intel: Top five analyst calls
12/31/20 Citi
easyJet downgraded to Sell from Neutral at Citi
12/17/20 Morgan Stanley
easyJet price target raised to 900 GBp from 800 GBp at Morgan Stanley
12/14/20 AlphaValue
easyJet upgraded to Reduce from Sell at AlphaValue
ESYJY easyJet
$0.00 /

+ (+0.00%)

Recommendations
KBC Group price target lowered to EUR 60 from EUR 61 at Deutsche Bank » 11:27
01/20/21
01/20
11:27
01/20/21
11:27
KBCSY

KBC Group

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KBCSY KBC Group
$0.00 /

+ (+0.00%)

01/14/21 Morgan Stanley
KBC Group price target raised to EUR 71 from EUR 67 at Morgan Stanley
01/11/21 Deutsche Bank
KBC Group downgraded to Hold from Buy at Deutsche Bank
01/07/21 Credit Suisse
KBC Group downgraded to Neutral from Outperform at Credit Suisse
01/07/21 Credit Suisse
KBC Group downgraded to Neutral from Outperform at Credit Suisse
Recommendations
Carl Zeiss Meditec price target raised to EUR 140 from EUR 120 at Deutsche Bank » 11:26
01/20/21
01/20
11:26
01/20/21
11:26
CZMWY

Carl Zeiss Meditec

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CZMWY Carl Zeiss Meditec
$0.00 /

+ (+0.00%)

CZMWY Carl Zeiss Meditec
$0.00 /

+ (+0.00%)

11/02/20 Deutsche Bank
Carl Zeiss Meditec price target raised to EUR 120 from EUR 110 at Deutsche Bank
10/23/20 UBS
Carl Zeiss Meditec downgraded to Neutral from Buy at UBS
07/17/20 Berenberg
Carl Zeiss Meditec price target raised to EUR 87 from EUR 81 at Berenberg
07/16/20 Deutsche Bank
Carl Zeiss Meditec price target lowered to EUR 110 at Deutsche Bank
Recommendations
AirBoss of America price target lowered to C$28 from C$31 at CIBC » 11:20
01/20/21
01/20
11:20
01/20/21
11:20
ABSSF

AirBoss of America

$0.00 /

+ (+0.00%)

CIBC analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABSSF AirBoss of America
$0.00 /

+ (+0.00%)

ABSSF AirBoss of America
$0.00 /

+ (+0.00%)

01/14/21 Canaccord
AirBoss of America price target lowered to C$27 from C$43 at Canaccord
12/18/20 TD Securities
AirBoss of America price target lowered to C$29 from C$32 at TD Securities
11/12/20 Stifel
AirBoss of America price target lowered to C$33 from C$34 at Stifel
11/12/20 TD Securities
AirBoss of America price target raised to C$32 from C$31 at TD Securities
ABSSF AirBoss of America
$0.00 /

+ (+0.00%)

Options
Vertical call spread in energy ETF targets 26% return for 2021 » 11:20
01/20/21
01/20
11:20
01/20/21
11:20
XLE

Energy Select Sector SPDR

$43.50 /

-0.12 (-0.28%)

Vertical call spread in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XLE Energy Select Sector SPDR
$43.50 /

-0.12 (-0.28%)

XLE Energy Select Sector SPDR
$43.50 /

-0.12 (-0.28%)

07/06/20 Goldman Sachs
Rattler Midstream downgraded to Neutral from Buy at Goldman Sachs
XLE Energy Select Sector SPDR
$43.50 /

-0.12 (-0.28%)

XLE Energy Select Sector SPDR
$43.50 /

-0.12 (-0.28%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.